E-LIB Suche - Ergebnisse für: Goldlust, Samuel A.

1

Phase 1 trial of TPI 287, a microtubule stabilizing agent, ..:

Goldlust, Samuel A ; Nabors, Louis B ; Hsu, Sigmund...
Neuro-Oncology Advances. 6 (2024) 1 - p. , 2024

Link: https://doi.org/10.1093/..

2

Phase 1 study of concomitant tumor treating fields and temo..:

Goldlust, Samuel A ; Singer, Samuel ; Cappello, Lori A...
Neuro-Oncology Advances. 6 (2024) 1 - p. , 2024

Link: https://doi.org/10.1093/..

3

CTIM-18. NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III ..:

Lassman, Andrew ; Polly, Mei-Yin ; Iwamoto, Fabio...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v65-v65 , 2023

Link: https://doi.org/10.1093/..

4

CTNI-67. FIRST IN HUMAN STUDY OF DSP-0390, AN ORAL EMOPAMIL..:

Arakawa, Yoshiki ; Goldlust, Samuel ; Colman, Howard...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v92-v92 , 2023

Link: https://doi.org/10.1093/..

5

QOL-15. THE PIVOTAL TRIDENT STUDY OF TUMOR TREATING FIELDS ..:

Shi, Wenyin ; Glas, Martin ; Roberge, David...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v251-v252 , 2023

Link: https://doi.org/10.1093/..

6

Older patients with primary central nervous system lymphoma..:

David, Kevin A. ; Sundaram, Suchitra ; Kim, Seo‐Hyun...
American Journal of Hematology. 98 (2023) 6 - p. 900-912 , 2023

Link: https://doi.org/10.1002/..

7

10007-ACT-2 FIRST IN HUMAN STUDY OF DSP-0390, AN ORAL EMOPA..:

Arakawa, Yoshiki ; Goldlust, Samuel A ; Colman, Howard...
Neuro-Oncology Advances. 5 (2023) Supplement_5 - p. v2-v2 , 2023

Link: https://doi.org/10.1093/..

8

ACT-13 DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INH..:

Yoshiki, Arakawa ; Reardon, David ; Narita, Yoshitaka...
Neuro-Oncology Advances. 4 (2022) Supplement_3 - p. iii8-iii9 , 2022

Link: https://doi.org/10.1093/..

9

CLRM-09 FIRST-LINE Tumor TREATING FIELDS (200 KHZ) THERAPY ..:

Shi, Wenyin ; Kleinberg, Lawrence ; Jeyapalan, Suriya A...
Neuro-Oncology Advances. 4 (2022) Supplement_1 - p. i7-i8 , 2022

Link: https://doi.org/10.1093/..

10

RTID-03. DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) I..:

Reardon, David A ; Narita, Yoshitaka ; Arakawa, Yoshiki...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii249-vii250 , 2022

Link: https://doi.org/10.1093/..

11

CTNI-27. MULTI-CENTER, PHASE 2 STUDY EVALUATING THE PHARMAC..:

Wen, Patrick Y ; de Groot, John ; Battiste, James...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii76-vii77 , 2022

Link: https://doi.org/10.1093/..

12

CTIM-27. AUTOLOGOUS TUMOR LYSATE-LOADED DENDRITIC CELL VACC..:

Liau, Linda M ; Ashkan, Keyoumars ; Brem, Steven...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii66-vii66 , 2022

Link: https://doi.org/10.1093/..

13

Tumor Treating Fields (TTFields) therapy vs physicians' cho..:

Zhu, Jay-Jiguang ; Goldlust, Samuel A. ; Kleinberg, Lawrence R....
Discover Oncology. 13 (2022) 1 - p. , 2022

Link: https://doi.org/10.1007/..

14

CTNI-09. TRIDENT PHASE 3 TRIAL (EF-32): FIRST-LINE TUMOR TR..:

Shi, Wenyin ; Kleinberg, Lawrence ; Jeyapalan, Suriya...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi60-vi61 , 2021

Link: https://doi.org/10.1093/..

15

Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A R..:

Goldlust, Samuel A. ; Kavoosi, Mojgan ; Nezzer, Jennifer...
Toxins. 13 (2021) 4 - p. 235 , 2021

Link: https://doi.org/10.3390/..